22 April 2008 - GlaxoSmithKline Oncology will present a wide range of new data at the annual American Society of Clinical Oncology (ASCO) meeting in Chicago starting Friday, May 30th......
Non-Small Cell Lung Cancer : Preoperative treatment with pazopanib (GW786034) a multikinase angiogenesis inhibitor in early stage non-small cell lung cancer (NSCLC): a proof-of-concept phase II study...
Small Cell Lung Cancer : Topotecan/cisplatin (TP) compared to cisplatin/etoposide (PE) for patients with extensive disease - small cell lung cancer (ED-SCLC): final results of a randomised phase III trial... GlaxoSmithKline's Press release -
